Lu Zhong

402 total citations
20 papers, 287 citations indexed

About

Lu Zhong is a scholar working on Molecular Biology, Oncology and Ophthalmology. According to data from OpenAlex, Lu Zhong has authored 20 papers receiving a total of 287 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Ophthalmology. Recurrent topics in Lu Zhong's work include Retinal Diseases and Treatments (3 papers), Gut microbiota and health (3 papers) and Food composition and properties (2 papers). Lu Zhong is often cited by papers focused on Retinal Diseases and Treatments (3 papers), Gut microbiota and health (3 papers) and Food composition and properties (2 papers). Lu Zhong collaborates with scholars based in China, Germany and Hong Kong. Lu Zhong's co-authors include Shaohui Tang, Kaiyin He, Yuting Li, Xin Guo, Xiaojuan Peng, Chuan Liu, Hong Liu, Ya Tu, Xin Zhou and Ying Shi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Frontiers in Microbiology.

In The Last Decade

Lu Zhong

20 papers receiving 282 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lu Zhong China 10 87 86 63 44 41 20 287
Xinyu Huang China 12 93 1.1× 143 1.7× 15 0.2× 21 0.5× 12 0.3× 39 450
Julia Guerrero Chile 12 127 1.5× 64 0.7× 98 1.6× 58 1.3× 12 0.3× 24 401
Huiwen Xu China 9 56 0.6× 213 2.5× 26 0.4× 10 0.2× 12 0.3× 13 388
Costas Haitoglou Greece 11 35 0.4× 95 1.1× 61 1.0× 7 0.2× 19 0.5× 24 360
Nicole Bertin Italy 11 51 0.6× 140 1.6× 90 1.4× 4 0.1× 47 1.1× 27 483
Faisal Ahmed United States 11 36 0.4× 152 1.8× 22 0.3× 109 2.5× 11 0.3× 20 333
Tomoya Sugiyama Japan 10 35 0.4× 215 2.5× 26 0.4× 18 0.4× 15 0.4× 32 383
Qixiang Zhao China 10 70 0.8× 200 2.3× 13 0.2× 13 0.3× 11 0.3× 18 452

Countries citing papers authored by Lu Zhong

Since Specialization
Citations

This map shows the geographic impact of Lu Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Zhong more than expected).

Fields of papers citing papers by Lu Zhong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Zhong. The network helps show where Lu Zhong may publish in the future.

Co-authorship network of co-authors of Lu Zhong

This figure shows the co-authorship network connecting the top 25 collaborators of Lu Zhong. A scholar is included among the top collaborators of Lu Zhong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu Zhong. Lu Zhong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhong, Lu, et al.. (2024). Identification of the Vulnerability of Atherosclerotic Plaques by a Photoacoustic/Ultrasonic Dual-Modal cRGD Nanomolecular Probe. International Journal of Nanomedicine. Volume 19. 9395–9410. 2 indexed citations
2.
Wang, Min, Xiaojuan Peng, Lu Zhong, et al.. (2023). Fish consumption in multiple health outcomes: an umbrella review of meta-analyses of observational and clinical studies. Annals of Translational Medicine. 11(3). 152–152. 11 indexed citations
3.
Peng, Xiaojuan, Sisi Chen, Lu Zhong, et al.. (2023). Cyclocarya paliurus leaves extracts alleviate metabolic phenotypes in Chinese T2DM patients by modulating gut microbiota and metabolites: a clinical randomized controlled trial. Frontiers in Endocrinology. 14. 1176256–1176256. 3 indexed citations
5.
Zhong, Lu, Xiaojuan Peng, Qing Li, et al.. (2022). Polysaccharides and flavonoids from cyclocarya paliurus modulate gut microbiota and attenuate hepatic steatosis, hyperglycemia, and hyperlipidemia in nonalcoholic fatty liver disease rats with type 2 diabetes mellitus. International Journal of Diabetes in Developing Countries. 43(2). 317–327. 5 indexed citations
6.
Yuan, Yuan, Yunhui Gong, Lu Zhong, et al.. (2022). Circular RNA expression profile and competing endogenous RNA regulatory network in preeclampsia. Placenta. 119. 32–38. 6 indexed citations
7.
Shi, Ying, Lu Zhong, Yuting Li, et al.. (2021). Repulsive Guidance Molecule b Deficiency Induces Gut Microbiota Dysbiosis and Increases the Susceptibility to Intestinal Inflammation in Mice. Frontiers in Microbiology. 12. 648915–648915. 18 indexed citations
8.
Tang, Huijun, et al.. (2021). Insulin-Like Growth Factor 1 Receptor Drives Hepatocellular Carcinoma Growth and Invasion by Activating Stat3-Midkine-Stat3 Loop. Digestive Diseases and Sciences. 67(2). 569–584. 15 indexed citations
9.
Liu, Chuan, Qian Zhao, Lu Zhong, et al.. (2021). Tibetan medicine Ershiwuwei Lvxue Pill attenuates collagen-induced arthritis via inhibition of JAK2/STAT3 signaling pathway. Journal of Ethnopharmacology. 270. 113820–113820. 31 indexed citations
10.
Zhong, Lu, et al.. (2021). Evaluation of phacoemulsification (ultrasound) cataract surgery on the dynamics of the anterior segment of primary angle closure by AS-OCT.. American Journal of Translational Research. 13(4). 3156–3164. 1 indexed citations
11.
He, Kaiyin, Yuting Li, Xin Guo, Lu Zhong, & Shaohui Tang. (2020). Food groups and the likelihood of non-alcoholic fatty liver disease: a systematic review and meta-analysis. British Journal Of Nutrition. 124(1). 1–13. 79 indexed citations
12.
Yi, Tingzhuang, Tonghua Wang, Ying Shi, et al.. (2019). Long noncoding RNA 91H overexpression contributes to the growth and metastasis of HCC by epigenetically positively regulating IGF2 expression. Liver International. 40(2). 456–467. 17 indexed citations
13.
Wang, Tonghua, Rui Zhan, Jiao Lu, et al.. (2019). Grain consumption and risk of gastric cancer: a meta-analysis. International Journal of Food Sciences and Nutrition. 71(2). 164–175. 19 indexed citations
14.
Guo, Jie, Lu Zhong, Chunhui Jiang, et al.. (2014). Clinical and optic coherence tomography findings of focal choroidal excavation in Chinese patients. BMC Ophthalmology. 14(1). 63–63. 19 indexed citations
15.
Zhong, Lu, et al.. (2014). Comparative proteomic analysis of plasma proteins in patients with age-related macular degeneration.. SHILAP Revista de lepidopterología. 7(2). 256–63. 6 indexed citations
16.
Liu, Hong, et al.. (2009). Macular Abnormality Observed by Optical Coherence Tomography in Children With Amblyopia Failing to Achieve Normal Visual Acuity After Long-Term Treatment. Journal of Pediatric Ophthalmology & Strabismus. 47(1). 17–23. 21 indexed citations
17.
Zhong, Lu. (2007). The Association of Paraoxonase-1 192 Gln/Arg and Paraoxonase-2 311 Cys/Ser Gene Polymorphisms with Macrovascular Disease in Type 2 Diabetes Mellitus Patients. 3 indexed citations
18.
Xiong, Jian, Ling Zhang, Lu Zhong, et al.. (2007). A phase II trial of modified FOLFOX as first-line chemotherapy in advanced colorectal cancer. Anti-Cancer Drugs. 18(9). 1103–1107. 4 indexed citations
19.
Xiong, Jian, Feng Miao, Feng Qiu, et al.. (2007). Phase II trial of low-dose gemcitabine in prolonged infusion and cisplatin for advanced non-small cell lung cancer. Lung Cancer. 60(2). 208–214. 9 indexed citations
20.
Zhong, Lu, et al.. (2000). Study on blood coagulant/fibrinolytic activity at plasma and monocytic levels in coronary heart disease patients with blood-stasis syndrome of traditional chinese medicine. Chinese Journal of Integrated Traditional and Western Medicine. 6(3). 234–234. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026